FEBS

Workshop

Print Friendly, PDF & Email
MONDAY, SEPTEMBER 3

15:00 – 16:30 Pre-Conference Workshop  'Innovative Medicine Does Not Exist Without Knowledge Transfer' 
Dr. Sandor G. Vari

International Research and Innovation in Medicine Program, 
Cedars - Sinai Medical Center, Los Angeles, USA, Sandor.Vari @ cshs.org
Venue: Palladin Institute of Biochemistry, 9 Leontovycha St., Conference Hall.

Introduction: Most scientists are self-directed, and they desire to make discoveries independently. In the 21st Century, this situation is changing rapidly and nowadays researchers and research institutions look for collaborations to enable capacity building and offer multiple opportunities that surpass the limitations of a single institution and scarce resources.

Methods: Develop – It is the nature of research Scientists to develop new methods, markers, tests, and instruments. Aware – Scientists realize the scientific value of their research and apply for protection of their research output. Protect – Technology transfer professionals initiate Intellectual Property Protection. Accept – Scientists publish their results to motivate other scientists, advance their research, and gain acceptance of novelty by the scientific community. Investigate – Bringing into medical practice the newly developed diagnostic or treatment modalities starts with market research to investigate the market value and benefit for medical practice. Demonstrate – Initiate clinical research to demonstrate that the invented methods, markers, tests, or instruments can perform the predicted non-harmful, well-defined medical applications. Agree – The medical community accepts, and the interested companies realize the market opportunities. Benefit – Investigate the cost versus benefit of the new application in medical practice.

Results: Researchers: are aware of the intellectual property (IP) potential of their research; protect their results and make intelligent decisions to avoid premature publication; understand the basics of IP management to maximize the economic benefit from public research; develop new products and services; publish results to investigate whether the scientific community; accept the novelty of the research work; investigate the relationship between basic research and clinical research; demonstrate the advantages of the novel drugs, markers, diagnostic and treatment methods in clinical research; agree to transfer results of the translational research into the practice; and have a clear view of the cost benefit of healthcare technologies to make diagnostic procedures and therapies more effective.

Discussion – Conclusion: The ongoing process of knowledge integration is removing territorial borders and fostering research collaborations to expedite laboratory research transformation into practice via the steps of Knowledge Tranfer: Develop: (1) Aware, (2) Protect, (3) Accept, (4) Investigate, (5) Demonstrate, (6) Agree, and (7) Benefit. The Knowledge Transfer Chain TM: Develop – Aware – Protect – Accept – Investigate – Demonstrate – Agree – Benefit (DAPAIDEB) helps the advancements of biochemistry and molecular biology gained through various laboratory techniques to develop new ways to treat patients and are key for Innovative Medicine.

Acknowledgement: We thank Cedars - Sinai Medical Center’s International Research and Innovation in Medicine Program, the Association for Regional Cooperation in the Fields of Health, Science and Technology (RECOOP HST Association) for their support.

You are here: Home Conference Programme Workshop